Gilead Sciences Inc (GILD)
64.60
-0.32
(-0.49%)
USD |
NASDAQ |
May 09, 16:00
65.00
+0.40
(+0.62%)
After-Hours: 04:05
Gilead Sciences Net Income (TTM): 484.00M for March 31, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 484.00M |
December 31, 2023 | 5.664B |
September 30, 2023 | 5.875B |
June 30, 2023 | 5.484B |
March 31, 2023 | 5.583B |
December 31, 2022 | 4.592B |
September 30, 2022 | 3.334B |
June 30, 2022 | 4.137B |
March 31, 2022 | 4.515B |
December 31, 2021 | 6.225B |
September 30, 2021 | 7.394B |
June 30, 2021 | 5.162B |
March 31, 2021 | 301.00M |
December 31, 2020 | 123.00M |
September 30, 2020 | 1.268B |
June 30, 2020 | -257.00M |
March 31, 2020 | 4.962B |
December 31, 2019 | 5.386B |
September 30, 2019 | 2.693B |
June 30, 2019 | 5.955B |
March 31, 2019 | 5.892B |
December 31, 2018 | 5.455B |
September 30, 2018 | 1.587B |
June 30, 2018 | 2.208B |
March 31, 2018 | 3.464B |
Date | Value |
---|---|
December 31, 2017 | 4.628B |
September 30, 2017 | 11.60B |
June 30, 2017 | 12.21B |
March 31, 2017 | 12.64B |
December 31, 2016 | 13.50B |
September 30, 2016 | 15.08B |
June 30, 2016 | 16.35B |
March 31, 2016 | 17.34B |
December 31, 2015 | 18.11B |
September 30, 2015 | 16.91B |
June 30, 2015 | 15.04B |
March 31, 2015 | 14.21B |
December 31, 2014 | 12.10B |
September 30, 2014 | 9.406B |
June 30, 2014 | 7.463B |
March 31, 2014 | 4.580B |
December 31, 2013 | 3.075B |
September 30, 2013 | 3.046B |
June 30, 2013 | 2.933B |
March 31, 2013 | 2.872B |
December 31, 2012 | 2.592B |
September 30, 2012 | 2.494B |
June 30, 2012 | 2.560B |
March 31, 2012 | 2.594B |
December 31, 2011 | 2.804B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-257.00M
Minimum
Jun 2020
7.394B
Maximum
Sep 2021
3.944B
Average
4.777B
Median
Net Income (TTM) Benchmarks
Amgen Inc | 3.763B |
CymaBay Therapeutics Inc (DELISTED) | -105.37M |
Bristol-Myers Squibb Co | -6.148B |
Eli Lilly and Co | 6.138B |
Xilio Therapeutics Inc | -76.40M |